Confounding by indication limits conclusions of study of palivizumab effectiveness

Thomas G. Boyce, Ram Yogev, John Devincenzo, Leonard R. Krilov

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Article numbere20164247A
JournalPediatrics
Volume139
Issue number3
DOIs
StatePublished - Mar 1 2017

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Confounding by indication limits conclusions of study of palivizumab effectiveness. / Boyce, Thomas G.; Yogev, Ram; Devincenzo, John; Krilov, Leonard R.

In: Pediatrics, Vol. 139, No. 3, e20164247A, 01.03.2017.

Research output: Contribution to journalLetter

Boyce, Thomas G. ; Yogev, Ram ; Devincenzo, John ; Krilov, Leonard R. / Confounding by indication limits conclusions of study of palivizumab effectiveness. In: Pediatrics. 2017 ; Vol. 139, No. 3.
@article{c8a31d0673dc4f169706ef7a69dd2d6b,
title = "Confounding by indication limits conclusions of study of palivizumab effectiveness",
author = "Boyce, {Thomas G.} and Ram Yogev and John Devincenzo and Krilov, {Leonard R.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1542/peds.2016-4247A",
language = "English (US)",
volume = "139",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Confounding by indication limits conclusions of study of palivizumab effectiveness

AU - Boyce, Thomas G.

AU - Yogev, Ram

AU - Devincenzo, John

AU - Krilov, Leonard R.

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85015979332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015979332&partnerID=8YFLogxK

U2 - 10.1542/peds.2016-4247A

DO - 10.1542/peds.2016-4247A

M3 - Letter

VL - 139

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

M1 - e20164247A

ER -